Comparison of predictive value of risk scores for gastrointestinal bleeding in antiplatelet therapy

References

• Shengshou HU, Runlin GAO, Lisheng LIU. Summary of the 2018 report on cardiovascular diseases in China. Chinese Circulation Journal March, 2019;34(3):209–220.
   Google Scholar
• Shiyi BAI. The current situation and development prospect of surgical nursing of cerebrovascular disease. Journal of Cardiovascular Surgery(Electronic Edition) 2020;9(2):234–235.
   Google Scholar
• Longde WANG, Jianmin LIU, Yi YANG. The prevention and treatment of stroke still face huge challenges ——brief report on stroke prevention and treatment in China, 2018. Chinese Circulation Journal 2019; 34(2):105–119.
   Google Scholar
• Xuejiao FENG, Hui ZOU, Qiong YU. Analysis on the R&D and market for antithrombotic drugs. JIANGXI SCIENCE 2019;37(6):989–996.
   Google Scholar
• Frontera JA, Lewin JJ, Rabinstein AA. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine. Neurocrit Care 2016;24(1):6–46.
   PubMed Web of Science ®Google Scholar
• Grzegorski T, Andrzejewska N, Kaźmierski R. Reversal of antithrombotic treatment in intracranial hemorrhage-A review of current strategies and guidelines. Neurol Neurochir Pol 2015;49(4):278–289. 10.1016/j.pjnns.2015.06.003.
   PubMedGoogle Scholar
• Li-ying GONG, Le-Hong YUAN, Jie HUANG. Research progress of oral antithrombotic drugs. Chin J Clin Pharmacol 2016;32(3):279–282.
   Google Scholar
• Yasuda H, Matsuo Y, Sato Y. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med 2015;4(1):40–6.9. 10.5492/wjccm.v4.i1.40.
   PubMedGoogle Scholar
• Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med 2005;143(4):241–250. 10.7326/0003-4819-143-4-200508160-00005.
   PubMed Web of Science ®Google Scholar
• Sørensen R, Hansen ML, Abildstrom SZ. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 2009;374(9706):1967–1974. 10.1016/S0140-6736(09)61751-7.
   PubMed Web of Science ®Google Scholar
• Van Leerdam ME, Vreeburg EM, Rauws EA. Acute upper GI bleeding: did anything change? time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003;98(7):1494–1499. 10.1111/j.1572-0241.2003.07517.x.
   PubMed Web of Science ®Google Scholar
• Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60(10):1327–1335. 10.1136/gut.2010.228437.
   PubMed Web of Science ®Google Scholar
• Rosenstock SJ, Møller MH, Larsson H. Improving quality of care in peptic ulcer bleeding: nationwide cohort study of 13,498 consecutive patients in the Danish clinical register of emergency surgery. Am J Gastroenterol 2013;108(9):1449–1457. 10.1038/ajg.2013.162.
   PubMed Web of Science ®Google Scholar
• Hansen ML, Sørensen R, Clausen MT. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010;170(16):1433–1441. 10.1001/archinternmed.2010.271.
   PubMed Web of Science ®Google Scholar
• Shimomura A, Nagata N, Shimbo T. A new predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: a cohort study. J Gastroenterol Hepatol 2018;33(1):164–171. 10.1111/jgh.13830.
   PubMed Web of Science ®Google Scholar
• Ruíz-Giménez N, Suárez C, González R. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE registry. Thromb Haemost 2008;100(07):26–31. 10.1160/TH08-03-0193.
   PubMedGoogle Scholar
• Cuschieri JR, Drawz P, Falck-Ytter Y, Wong RC. Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel. J Dig Dis 2014;15(4):195–201. 10.1111/1751-2980.12123.
   PubMed Web of Science ®Google Scholar
• de Groot NL, Hagenaars MP, Smeets HM, Steyerberg EW, Siersema PD, van Oijen MG. Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large dutch cohorts. J Gastroenterol 2014;49(2):245–253. 10.1007/s00535-013-0817-y.
   PubMed Web of Science ®Google Scholar
• Schulman S, Kearon C. Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3(4):692–694.
   PubMed Web of Science ®Google Scholar
• Urban P, Mehran R, Colleran R. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Eur Heart J 2019;40(31):2632–2653. 10.1093/eurheartj/ehz372.
   PubMed Web of Science ®Google Scholar
• Choudari CP, Palmer KR. Acute gastrointestinal haemorrhage in patients treated with anticoagulant drugs. Gut 1995;36(4):483–484. 10.1136/gut.36.4.483.
   PubMedGoogle Scholar
• Miao TIAN, Yalin FAN, Meiying WANG. The clinical characteristics and risk factors of dangerous acute upper gastrointestinal bleeding in patients treated by double antiplatelet drugs after PCI. Hebei Medical Journal 2020;42(16):2446–2450.
   Google Scholar
• Nieto JA, Solano R, Trapero Iglesias N. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism. Thromb Res 2013;132(2):175–179. 10.1016/j.thromres.2013.06.019.
   PubMedGoogle Scholar
• Iantorno M, Weintraub WS, Garcia-Garcia HM. Genetic and nongenetic implications of racial variation in response to antiplatelet therapy. Am J Cardiol 2019;123(11):1878–1883. 10.1016/j.amjcard.2019.02.047.
   PubMedGoogle Scholar
• Gaglia MA Jr., Lipinski MJ, Lhermusier T. Comparison of platelet reactivity in black versus white patients with acute coronary syndromes after treatment with ticagrelor. Am J Cardiol 2017;119(8):1135–1140. 10.1016/j.amjcard.2017.01.002.
   PubMedGoogle Scholar
• Yao X, Gersh BJ, Sangaralingham LR. Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA risk scores in predicting non-vitamin K antagonist oral anticoagulants associated bleeding in patients with atrial fibrillation. Am J Cardiol 2017;120(9):1549–1556. 10.1016/j.amjcard.2017.07.051.
   PubMedGoogle Scholar